Ron Gansevoort

Prof. Ron Gansevoort is a Professor of Medicine at the University of Groningen's Faculty of Medical Sciences, affiliated with the UMCG. He leads research in nephrology, focusing on chronic kidney disease (CKD), autosomal dominant polycystic kidney disease (ADPKD), and cardiovascular comorbidities. His work emphasizes epidemiology, prevention strategies, and biomarker development (e.g., albuminuria).

Roles & Affiliations

• Principal Investigator of the Renal Lifecycle trial and Check@Home consortium
• Co-leader of the DIPAK and EuroCYST consortia
• Member of steering committees for PREVEND, FIGARO, and FIDELIO studies
• Director of the Groningen Kidney Center (GKC)

Research Interests

• Mechanisms of CKD progression and cardiovascular risk
• Novel therapeutic targets in ADPKD (e.g., SGLT2 inhibitors)
• Population-based studies like the Prevention of Renal and Vascular End-stage Disease (PREVEND)
• Clinical trials evaluating tolvaptan and other treatments

Awards

• 2018: Fellow of the American Society of Nephrology
• 2011: United States Kidney Foundation Distinguished International Medal
• 2019: Top 5 best publication in Journal of the American Society of Nephrology

Grants & Leadership

• Principal Investigator for multiple NIH/EU-funded projects
• Supervised 31 PhD/Master's students
• Editorial roles in leading nephrology journals

Labs & Collaborations

• Groningen Kidney Center (GKC): Focus on translational nephrology research
• Cardiovascular Centre (CVC): Cross-disciplinary heart-kidney interaction studies
• International networks: DIPAK, EuroCYST, and the CONNECT Action